Zacks Research Has Negative Forecast for DLB Q1 Earnings

by · The Cerbat Gem

Dolby Laboratories, Inc. (NYSE:DLB – Free Report) – Research analysts at Zacks Research cut their Q1 2026 earnings estimates for shares of Dolby Laboratories in a note issued to investors on Tuesday, October 29th. Zacks Research analyst V. Doshi now forecasts that the electronics maker will post earnings of $0.71 per share for the quarter, down from their prior estimate of $0.72. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.71 per share. Zacks Research also issued estimates for Dolby Laboratories’ Q2 2026 earnings at $0.74 EPS and FY2026 earnings at $2.81 EPS.

Dolby Laboratories (NYSE:DLB – Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The electronics maker reported $0.47 EPS for the quarter, beating analysts’ consensus estimates of $0.33 by $0.14. The business had revenue of $288.82 million during the quarter, compared to analysts’ expectations of $286.26 million. Dolby Laboratories had a net margin of 16.87% and a return on equity of 10.66%.

Separately, Barrington Research reissued an “outperform” rating and set a $100.00 price objective on shares of Dolby Laboratories in a research report on Friday, September 20th.

View Our Latest Research Report on Dolby Laboratories

Dolby Laboratories Stock Performance

NYSE DLB opened at $72.00 on Friday. Dolby Laboratories has a 52-week low of $66.35 and a 52-week high of $90.06. The business has a 50 day simple moving average of $72.82 and a 200 day simple moving average of $76.55. The stock has a market cap of $6.87 billion, a price-to-earnings ratio of 33.32 and a beta of 0.97.

Dolby Laboratories declared that its Board of Directors has authorized a share repurchase program on Wednesday, August 7th that allows the company to buyback $350.00 million in outstanding shares. This buyback authorization allows the electronics maker to reacquire up to 5% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

Dolby Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, August 27th. Shareholders of record on Monday, August 19th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.67%. The ex-dividend date was Monday, August 19th. Dolby Laboratories’s dividend payout ratio (DPR) is currently 54.79%.

Insider Transactions at Dolby Laboratories

In related news, CEO Kevin J. Yeaman sold 28,512 shares of the stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the completion of the transaction, the chief executive officer now owns 83,721 shares in the company, valued at approximately $6,205,400.52. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 39.54% of the company’s stock.

Hedge Funds Weigh In On Dolby Laboratories

Large investors have recently modified their holdings of the business. Boston Trust Walden Corp raised its holdings in Dolby Laboratories by 185.3% during the third quarter. Boston Trust Walden Corp now owns 1,075,076 shares of the electronics maker’s stock worth $82,276,000 after acquiring an additional 698,283 shares in the last quarter. Acadian Asset Management LLC raised its stake in shares of Dolby Laboratories by 39.8% during the 2nd quarter. Acadian Asset Management LLC now owns 652,651 shares of the electronics maker’s stock worth $51,698,000 after purchasing an additional 185,884 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Dolby Laboratories by 27.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 792,828 shares of the electronics maker’s stock valued at $62,817,000 after buying an additional 168,744 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Dolby Laboratories by 1.7% in the first quarter. Vanguard Group Inc. now owns 6,502,463 shares of the electronics maker’s stock valued at $544,711,000 after buying an additional 107,713 shares in the last quarter. Finally, AQR Capital Management LLC increased its holdings in Dolby Laboratories by 16.2% during the second quarter. AQR Capital Management LLC now owns 627,160 shares of the electronics maker’s stock worth $49,690,000 after buying an additional 87,298 shares during the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Further Reading